Regression discontinuity analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of harm. (2022)
Attributed to:
Statistical Methods for Improving Causal Analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jclinepi.2021.10.003
PubMed Identifier: 34648942
Publication URI: http://europepmc.org/abstract/MED/34648942
Type: Journal Article/Review
Volume: 141
Parent Publication: Journal of clinical epidemiology
ISSN: 0895-4356